API

Jubilant develops a range of pharmaceutical bulk actives and intermediates in therapeutic categories of the central nervous system, cardiovascular system, gastro-intestinal and anti-infectives. In our backward integrated structure, these API’s are the core of our finished dosage form developments.

Research and Development is the key driver for API business and this is supported by 2 R&D centers:

• R&D center at Delhi, India housed in a 40,000 sq.ft. area with more than 100 highly skilled scientists
• R&D center at the manufacturing location in Nanjangud, India which focuses on process development and improvement

The pharmaceutical manufacturing plants are fully conforming to c-GMP guidelines and are approved by various regulatory authorities such as US FDA and TGA.